ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Omnicell Inc

Omnicell Inc (OMCL)

44.32
-0.20
(-0.45%)
Closed January 02 4:00PM
45.14
0.82
( 1.85% )
Pre Market: 6:41AM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
45.14
Bid
42.00
Ask
46.00
Volume
328
0.00 Day's Range 0.00
25.12 52 Week Range 55.745
Market Cap
Previous Close
44.32
Open
-
Last Trade
1
@
45.13
Last Trade Time
06:41:39
Financial Volume
-
VWAP
-
Average Volume (3m)
590,160
Shares Outstanding
46,316,825
Dividend Yield
-
PE Ratio
-100.77
Earnings Per Share (EPS)
-0.44
Revenue
1.15B
Net Profit
-20.37M

About Omnicell Inc

Omnicell provides automation and business analytics software for healthcare providers. The automation and analytics segment manufactures medication dispensing systems, pharmacy inventory management systems, and related software. The medication adherence segment sells products like consumable medicat... Omnicell provides automation and business analytics software for healthcare providers. The automation and analytics segment manufactures medication dispensing systems, pharmacy inventory management systems, and related software. The medication adherence segment sells products like consumable medication blister cards and packaging equipment to help administer medication outside of a hospital setting. Omnicell generates the vast majority of its revenue in the United States. Show more

Sector
Electronic Computers
Industry
Electronic Computers
Headquarters
Wilmington, Delaware, USA
Founded
-
Omnicell Inc is listed in the Electronic Computers sector of the NASDAQ with ticker OMCL. The last closing price for Omnicell was $44.32. Over the last year, Omnicell shares have traded in a share price range of $ 25.12 to $ 55.745.

Omnicell currently has 46,316,825 shares outstanding. The market capitalization of Omnicell is $2.05 billion. Omnicell has a price to earnings ratio (PE ratio) of -100.77.

OMCL Latest News

Omnicell Announces OmniSphere

Next-generation, cloud native, software workflow engine and data platform intended to seamlessly integrate enterprise robotics and smart devices across the continuum of care Company Showcases New...

Omnicell to Present at the Piper Sandler 36th Annual Healthcare Conference

Omnicell, Inc. (Nasdaq:OMCL), a leader in transforming the pharmacy care delivery model, announced that it will present at the Piper Sandler 36th Annual Healthcare Conference on Tuesday, December...

Omnicell Announces Pricing of $150 Million Convertible Senior Notes Offering

Omnicell, Inc. (NASDAQ: OMCL) (“Omnicell”) today announced the pricing of $150.0 million aggregate principal amount of 1.00% Convertible Senior Notes due 2029 (the “notes”) in a private placement...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.611.369863013744.5345.542.2127657044.13647577CS
4-0.97-2.1036651485646.1147.8242.2151469045.08038791CS
122.866.7644276253542.2855.74539.0559016045.87263891CS
2618.871.374335611226.3455.74525.1255035942.40852632CS
529.1425.38888888893655.74525.1253609736.15388864CS
156-135.27-74.9792140125180.41182.7725.1253834862.42086682CS
260-35.66-44.133663366380.8187.28525.1245462476.50871486CS

OMCL - Frequently Asked Questions (FAQ)

What is the current Omnicell share price?
The current share price of Omnicell is $ 45.14
How many Omnicell shares are in issue?
Omnicell has 46,316,825 shares in issue
What is the market cap of Omnicell?
The market capitalisation of Omnicell is USD 2.05B
What is the 1 year trading range for Omnicell share price?
Omnicell has traded in the range of $ 25.12 to $ 55.745 during the past year
What is the PE ratio of Omnicell?
The price to earnings ratio of Omnicell is -100.77
What is the cash to sales ratio of Omnicell?
The cash to sales ratio of Omnicell is 1.79
What is the reporting currency for Omnicell?
Omnicell reports financial results in USD
What is the latest annual turnover for Omnicell?
The latest annual turnover of Omnicell is USD 1.15B
What is the latest annual profit for Omnicell?
The latest annual profit of Omnicell is USD -20.37M
What is the registered address of Omnicell?
The registered address for Omnicell is 251 LITTLE FALLS DRIVE, WILMINGTON, DELAWARE, 19808
What is the Omnicell website address?
The website address for Omnicell is www.omnicell.com
Which industry sector does Omnicell operate in?
Omnicell operates in the ELECTRONIC COMPUTERS sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
TGLTreasure Global Inc
$ 0.8273
(336.57%)
67.38M
MFImF International Ltd
$ 1.29
(77.25%)
19.83M
ONCOOnconetix Inc
$ 1.03
(58.19%)
15.04M
MGOLMGO Global Inc
$ 0.9128
(54.45%)
13.8M
BLRXBioLineRx Ltd
$ 0.3607
(41.12%)
21.13M
HWHHWH International Inc
$ 0.48
(-26.04%)
343.23k
RAINRain Enhancement Technologies Holdco Inc
 5.42
(-25.75%)
9.05k
COEPCoeptis Therapeutics Holdings Inc
$ 4.56
(-22.84%)
59.66k
IDAIT Stamp Inc
$ 0.531
(-22.25%)
1.71M
RMBIRichmond Mutual Bancorporation Inc
$ 11.01
(-20.73%)
3
TGLTreasure Global Inc
$ 0.8229
(334.25%)
67.56M
BLRXBioLineRx Ltd
$ 0.3667
(43.47%)
21.16M
MFImF International Ltd
$ 1.29
(77.25%)
19.83M
ONCOOnconetix Inc
$ 1.04
(59.73%)
15.04M
MGOLMGO Global Inc
$ 0.9192
(55.53%)
13.82M

Discussion

View Full Feed
$PennyMover $PennyMover 4 minutes ago

Needs updates 

GRLF
Nelson2 Nelson2 4 minutes ago
My thoughts exactly
My torment. Purchased good number of shares around $2.30. Do I sell when hits $4.60 doubling my money on those buys or hold like the hog at the trough? Concern is BB is overweight in my portfolio
These are the dilemmas that make this so much fun

BB
weedtrader420 weedtrader420 5 minutes ago
HBAR Cat Stevens Morning has Broken 🌉🌇 $0.50 TARGET
HBARUSD
powerwalker powerwalker 5 minutes ago
Borbon, I understand your point, but "way back when" the discussion was centered on a hostile takeover and how a "friendly" one could be structured. This was prior to the Preferred Stock's approval.

I still contend the Consortium was formed to be that "friendly" group when the time c
AVXL
Teddytropics Teddytropics 6 minutes ago
"Furthermore, Rennova expects to be able to monetize its convertible preferred stock and common stock in FOXO over time.”

How does that play out?

Appreciate it..
FOXO
glenn1919 glenn1919 6 minutes ago
rr.......rzlv.....ampx.......cgbs..................................https://stockcharts.com/h-sc/ui?s=rzlv&p=W&yr=1&mn=3&dy=0&id=p96837884856
ddls ddls 7 minutes ago
Market Research gives this an F.😎
BIEL
Menace212 Menace212 7 minutes ago
Anyone know anything about the eoy shareholders letter that was promised 
RSPI
TrendTrade2016 TrendTrade2016 7 minutes ago
MFI BREAKING 1.50
MFI
Hi_Lo Hi_Lo 8 minutes ago
Plus I said:

Show me an example where the SEC has forced a company to "remove" their 8K.

...which you didn't do because it happens so seldom.

Again, It's not the SEC's job to check for truthfullness in ANY filings from a company. It's the company's respos
CNNA IGEX MEDH
Teddytropics Teddytropics 9 minutes ago
Keep the company relevant info discussion coming..
RNVA
glenn1919 glenn1919 9 minutes ago
spcb......lidr......atai.......qsi.................................https://stockcharts.com/h-sc/ui?s=qsi&p=W&yr=1&mn=3&dy=0&id=p96837884856
BlazingStocks BlazingStocks 9 minutes ago
$ILLR News December 20, 2024

Triller Group Inc. Unveils Bold Vision and Exciting Business Updates During Investor Day
https://finance.yahoo.com/news/triller-group-inc-unveils-bold-140000772.html
ILLR
KVM KVM 10 minutes ago
And only way to exercise those warrants and not go over 9.9% is for very to issue more shares. So even more dilution coming.
VERI
Nelson2 Nelson2 10 minutes ago
Good skinny boyz

“To accompany the rebranding, BlackBerry unveiled a refreshed logo, website, and visual identity, which will be showcased at CES 2025 in Las Vegas.

GLTA
BB
SkeBallLarry SkeBallLarry 10 minutes ago
As far as I know, that's a yes .. !
MartinLutherKing MartinLutherKing 11 minutes ago
TransCode Therapeutics and Akribion Genomics Report Progress Developing CRISPR-Derived Technology for Cancer Treatment
March 11 2024 - 9:00AM

TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeuti
RNAZ
KVM KVM 11 minutes ago
U are right but Esousa paid for 8 mil shs up front so in theory own 8 mil shs even though did not exercise warrants of 3 mil +
VERI
capgain capgain 12 minutes ago
Yep, I don't know what to think. Don't want a Democrat in his place, but I don't trust him either. Trump did back him though??
SkeBallLarry SkeBallLarry 13 minutes ago
Tough task for Speaker Johnson today >

He can only afford to lose 1 defection ...
LWLG-Netherlands LWLG-Netherlands 13 minutes ago
“The left us in the dark” This sentence assumes you are part of the shareholders of this beautiful company. You are NOT. So please don’t act like you are 1 of the longs/believers. We don’t like your kind.
LWLG
Wingsjr Wingsjr 13 minutes ago
It means Bill Ackman got the nod from 47 to get the stock price up with no fear of SEC, it’s a big middle finger to GG. 😎 Price wise, 4-5 very short term, 6-8 short term and 8-12 Q4 going into 2026 until we know exactly what’s going to happen. Then it’s either back to 2 or Rocket to 30-70.
FNMA
glenn1919 glenn1919 13 minutes ago
tgl.....blrx.....chek.....onco................................https://stockcharts.com/h-sc/ui?s=tgl&p=W&yr=1&mn=3&dy=0&id=p96837884856

Your Recent History

Delayed Upgrade Clock